Logo
x

Search

Subscribe Now

Eye Diseases

Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases

Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases

  • September 21, 2021
BlueRock Collaborates with Fujifilm and Opsis to Discover and Develop Cell Therapies for Eye Diseases

BlueRock Collaborates with Fujifilm and Opsis to Discover and Develop Cell Therapies for Eye Diseases

  • May 18, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.